BlueHQ: The colorectal cancer patient support hub
Take control of your path with colorectal cancer at BlueHQ, a free support service for patients and caregivers powered by the Colorectal Cancer Alliance.
BlueHQ is support magnified
BlueHQ is your digital hub with personalized resources, tools, and communities. You can:
- Explore personalized resources
- Connect with your community
- Track treatments and office visits
- Access support from the Alliance
BlueHQ has the information I need without searching. I can also connect with the Alliance’s support team and other patients like me.
Knowledge and tools curated for you
The path with colorectal cancer is different for every patient and caregiver. BlueHQ suggests helpful tools and resources that align with your story. Get the information that matters.
Connect with others who get it
BlueHQ connects you to thousands of allies with similar experiences. In this community, you can skip the basics and get to what matters — how to cope with colorectal cancer.
Keep track of important details
Store notes from your journey — including doctor visits, counseling sessions, and more — safely and securely. Or use BlueHQ as a journal. You can search your notes later.
Improve your journey with BlueHQ
Stay in the know about CRC resources and news, keep track of personalized medical information, and connect with a community of allies.
More Alliance communities
Get connectedTop resources
HAI liver pump for mCRC offers second chances
Discover how Hope overcame stage IV colorectal cancer with an innovative HAI liver pump, staying active and proving that second chances are possible.
Video: United to End Colorectal Cancer
Allies shared their stories and the vital need to end colorectal cancer in this video presented at the national Blue Hope Bash in November 2024. The video features Bash co-chair and patient Alison Friedman.
Treatment for KRAS G12C-mutated metastatic CRC approved by FDA
The U.S. Food and Drug Administration has approved sotorasib in combination with panitumumab for the treatment of adult patients with KRAS G12C-mutated metastatic colorectal cancer.